c-Rel inhibitors (University of Pennsylvania)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namec-Rel inhibitors (University of Pennsylvania)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene c-Rel inhibitors
TargetsProto-oncogene c-Rel
Therapy Area/IndicationsEncephalomyelitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Pennsylvania
Active IndicationsN/A
Inactive IndicationsEncephalomyelitis

Other Information

ATC CodeN/A
Related LinksN/A